Study guide
1.2 EAU Guidelines Framework & Standard Setting
FEBU Part 1 Written European Board of Urology
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Exam Strategy
1.1 FEBU Part 1 Examination Structure & Logistics 1.2 EAU Guidelines Framework & Standard Setting 1.3 Clinical Decision-Making & MCQ Strategy 1.4 Professionalism and Safe Practice
2 Chapter 2: Genitourinary Anatomy & Renal Physiology
2.1 Upper Tract Anatomy & Retroperitoneal Relationships 2.2 Lower Urinary Tract Anatomy & Neuroanatomy 2.3 Renal Physiology, Glomerular Filtration & Acid-Base Balance
3 Chapter 3: Urological Pharmacology & Diagnostic Imaging
3.1 Lower Urinary Tract Pharmacotherapy 3.2 Antimicrobial Stewardship & Perioperative Care 3.3 Diagnostic Modalities: Ultrasound, CT, mpMRI & Nuclear Medicine
4 Chapter 4: Prostate Cancer: Diagnosis & Risk Stratification
4.1 PSA Kinetics, Biomarkers & Risk Assessment 4.2 Multiparametric MRI (PI-RADS) & Biopsy Strategies 4.3 Histopathological Grading (ISUP Gleason) & Staging
5 Chapter 5: Prostate Cancer: Localized & Advanced Management
5.1 Active Surveillance & Watchful Waiting 5.2 Radical Prostatectomy & Radiation Therapy 5.3 Biochemical Recurrence & Salvage Therapies 5.4 Metastatic & Castration-Resistant Prostate Cancer (CRPC)
6 Chapter 6: Bladder Cancer: Non-Muscle Invasive (NMIBC)
6.1 TURBT Technique & Pathological Staging 6.2 EAU Risk Stratification for NMIBC 6.3 Intravesical Chemotherapy & BCG Immunotherapy
7 Chapter 7: Muscle-Invasive Bladder Cancer & Upper Tract Urothelial Carcinoma
7.1 Muscle-Invasive Bladder Cancer (MIBC) Staging & Neoadjuvant Therapy 7.2 Radical Cystectomy & Urinary Diversion 7.3 Upper Tract Urothelial Carcinoma (UTUC)
8 Chapter 8: Renal Cell Carcinoma & Adrenal Neoplasms
8.1 Histological Subtypes, Genetics & Staging of RCC 8.2 Localized RCC: Nephron-Sparing Surgery & Radical Nephrectomy 8.3 Metastatic RCC & Targeted / Immunotherapy Regimens 8.4 Adrenal Masses & Incidentalomas
9 Chapter 9: Testicular Germ Cell Tumours & Penile Cancer
9.1 Testicular Cancer Diagnosis, Staging & Tumour Markers 9.2 Management of Seminoma (Stage I to Metastatic) 9.3 Management of Non-Seminoma (Stage I to Metastatic) 9.4 Penile Cancer: Staging, Organ-Sparing & Lymphadenectomy
10 Chapter 10: Benign Prostatic Hyperplasia & Lower Urinary Tract Symptoms
10.1 BPH Pathophysiology, Natural History & Clinical Evaluation 10.2 Medical Management of Male LUTS / BPO 10.3 Interventional & Surgical Management of BPO
11 Chapter 11: Functional Urology, Incontinence & Neuro-Urology
11.1 Urinary Incontinence in Men and Women, Fistulae & Urethral Diverticula 11.2 Overactive Bladder, Bladder Pain Syndrome & Pelvic Organ Prolapse 11.3 Neurogenic Lower Urinary Tract Dysfunction (NLUTD) 11.4 Urodynamic Studies: Indications, Technique & Interpretation
12 Chapter 12: Urolithiasis: Evaluation & Medical Management
12.1 Stone Pathophysiology & Risk Factors 12.2 Metabolic Evaluation & Dietary/Medical Stone Prevention 12.3 Acute Ureteric Colic & Medical Expulsive Therapy
13 Chapter 13: Endourology & Interventional Stone Management
13.1 Shock Wave Lithotripsy (SWL) 13.2 Ureteroscopy (URS) & Retrograde Intrarenal Surgery (RIRS) 13.3 Percutaneous Nephrolithotomy (PCNL) & Endourological Safety
14 Chapter 14: Infections, Andrology & Male Infertility
14.1 Localised & Systemic UTIs, Pyelonephritis, Urosepsis & Specific Infections 14.2 Prostatitis, Epididymo-Orchitis & Fournier Gangrene 14.3 Male Infertility: Evaluation & Surgical Management 14.4 Erectile Dysfunction, Peyronie Disease, Priapism & Gender-Affirming Surgery
15 Chapter 15: Paediatric Urology, Trauma & Renal Transplantation
15.1 Cryptorchidism, Hypospadias & PUJO 15.2 Vesicoureteral Reflux, Posterior Urethral Valves & Nocturnal Enuresis 15.3 Genitourinary Trauma: Kidney, Bladder & Urethra 15.4 Renal Failure, Dialysis Indications & Renal Transplantation
1.2 EAU Guidelines Framework & Standard Setting
Key Takeaways Explain This Topic AI
EBU recommends up-to-date textbooks and identifies the EAU Guidelines and Campbell Walsh Wein Urology as useful preparation sources; the exam also tests basic science.
EAU uses evidence levels and strong/weak recommendation ratings. Recommendation strength also considers certainty, benefits, harms and patient preferences.
EBU uses cohort-based standard setting with the average score and standard deviation; its public information supplies no fixed pass percentage or exact cut-off formula.
The examination features zero negative marking; candidates must record an answer for every single question, using structured evidence-based elimination to maximize scoring probability.
Last updated: November 2026
EAU Guidelines Framework & Standard Setting
EBU recommends preparation using up-to-date textbooks and identifies the EAU Guidelines and Campbell Walsh Wein Urology, 12th edition , as useful sources of consensus on urological management. The written examination covers the full spectrum of urology, including basic science. Clinical algorithms are important, but learning only treatment tables will leave gaps in anatomy, physiology, pathology and general specialist knowledge.
Use the current applicable guideline edition when studying a clinical decision. Read the surrounding explanation as well as the recommendation: its population, disease stage, treatment setting and contraindications determine whether it applies to the patient in the question.
Using Guidelines in Clinical Questions
A useful revision method is to organise a topic as a decision sequence:
Establish the diagnosis and urgency.
Identify the patient's stage, risk group and relevant comorbidities.
Select the investigation or treatment appropriate at that point in the pathway.
Check contraindications, patient preferences and the intended outcome.
Distinguish immediate stabilisation from definitive treatment and follow-up.
National practice and EAU recommendations can differ. For a practice question explicitly asking for an EAU recommendation, use the applicable EAU pathway. EBU's public examination page does not establish that every official item is derived exclusively from EAU recommendations or specify a preceding-calendar-year guideline cut-off. Candidates should use the reading guidance and instructions issued for their examination cycle.
Guidelines support clinical judgement; they are not legal mandates. Even a strong recommendation must be applied to the patient and setting described. A recommendation for a fit patient with localised disease cannot simply be transferred to a frail patient, someone with metastatic disease, or a patient with a contraindication.
Evidence Levels and Recommendation Strength
These answer different questions. A level of evidence describes the type of study underlying a statement. A recommendation strength expresses the panel's judgement about a clinical action after considering evidence certainty, benefits, harms and patient preferences.
The EAU Guidelines Office's July 2025 Development Handbook retains a modified Oxford Centre for Evidence-Based Medicine classification:
- Level Type of evidence
- 1a Meta-analysis of randomised trials
- 1b At least one randomised trial
- 2a A well-designed controlled study without randomisation
- 2b Another well-designed quasi-experimental study
- 3 Well-designed non-experimental studies, including comparative or correlation studies and case reports
- 4 Expert committee reports, opinions or clinical experience of respected authorities
Study design alone does not establish study quality. Consider bias, precision, consistency and relevance to the clinical question. A randomised trial can have important limitations, and several trials can yield conflicting estimates.
Strong and weak recommendations
EAU strength ratings draw on the principles of GRADE. Panels consider the quality and certainty of the evidence, effect size, benefits and harms, and the nature and variability of patient values and preferences.
A strong recommendation generally reflects greater confidence in the clinical choice, a favourable balance of benefit and harm, and/or relatively consistent patient preferences. Strong recommendations can support an intervention or advise against it.
A weak recommendation reflects greater uncertainty or a closer balance of benefits and harms and/or greater variation in preferences. Different choices may be appropriate after discussion with the patient.
Neither rating can be inferred from a single verb or from the evidence level alone. High-level evidence does not automatically yield a strong recommendation; a strong recommendation can sometimes be justified without randomised trials.
Worked examples
Partial nephrectomy for T1 renal tumours: EAU gives a strong recommendation to offer nephron-sparing surgery. For a fit patient with a technically suitable small renal mass, preservation of renal function is a central part of the decision.
MRI-positive prostate biopsy: For PI-RADS 4 or 5 lesions, EAU gives a weak recommendation to combine targeted biopsy with perilesional sampling. This describes sampling around the MRI target, not an instruction to perform a complete systematic template in every patient.
Medical expulsive therapy: EAU gives a strong recommendation to offer alpha-blockers as one option for distal ureteric stones of 5–10 mm in patients suitable for conservative management. This use is off-label. Regulatory labelling and recommendation strength are separate issues; off-label use is not automatically an incorrect answer.
For each example, retain the clinical conditions along with the intervention. A patient with an infected obstructed kidney needs urgent source control and antibiotics rather than routine conservative stone management.
Knowledge Grades in the European Training Requirements
The 2026 European Training Requirements (ETR) describe the curriculum expected of a trained urologist. The theoretical-knowledge sections use three grades:
Grade 1, basic: Basic understanding of the area.
Grade 2, intermediate: Partial mastery of the required knowledge and skills.
Grade 3, advanced: Full mastery of the required knowledge and skills.
These grades guide depth of learning; they are not published examination percentages. They also differ from the separately described levels of practical competence and supervision.
Do not classify a topic as basic merely because its surgery is specialised. For example, the ETR assigns grade 3 to knowledge of procedures performed in transgender individuals and their complications. Candidates should recognise the procedures and important urological complications, even if those operations are performed in a referral centre.
What EBU Publishes About Scoring
EBU applies cohort-based standard setting , considering the cohort's average score and standard deviation when determining the cut-off. It also states that there is no negative marking .
The public examination information does not provide a fixed percentage pass mark, a coefficient to subtract from the mean, or a candidate-facing formula for item deletion. Do not plan around an assumed 60–65% threshold or try to calculate a guaranteed number of correct answers from an unpublished formula.
A practice-test percentage is still useful for learning. Track errors by topic and by cause: missing knowledge, incorrect staging, overlooked contraindication or poor reading of the lead-in. These categories identify what to revise; they do not predict EBU's cut-off for a future cohort.
Answering Uncertain Questions
With no negative marking, record an answer for each item. Eliminate choices using the patient's actual findings rather than superficial wording rules. An option containing “always” is not automatically wrong, and an off-label drug is not automatically inappropriate.
For a hypothetical four-option question, if two options have been correctly excluded and the remaining two are equally plausible, random selection gives a 50% chance of success. The gain is conditional on that elimination being correct. Reviewing a clinical contraindication is more useful than treating confidence as a measured probability.
- Distinction Practical implication
- Evidence level versus strength rating Read both; one does not determine the other
- Strong versus weak recommendation Consider benefits, harms, certainty and preferences
- ETR knowledge grade versus exam weight Use the grade for depth, not predicted item count
Cohort setting versus a fixed pass percentage EBU determines the cut-off; no fixed public percentage is supplied
- No negative marking versus certainty Choose the best answer even when uncertain
- Official sources checked 6 November 2026
- EBU exam preparation and scoring
- ETR Urology 2026, grade definitions and curriculum
- EAU Development Handbook, July 2025, pp.13–15
- EAU prostate biopsy recommendations
- EAU stone-management recommendations
- EAU renal tumour management